Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2261) 2261
Book Chapter (32) 32
Magazine Article (14) 14
Publication (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pembrolizumab (2298) 2298
science & technology (1594) 1594
life sciences & biomedicine (1567) 1567
oncology (1018) 1018
immunotherapy (987) 987
humans (740) 740
nivolumab (697) 697
patients (587) 587
melanoma (580) 580
metastasis (549) 549
chemotherapy (506) 506
cancer (455) 455
immune checkpoint (454) 454
lung cancer (425) 425
tumors (412) 412
cancer therapies (402) 402
metastases (376) 376
clinical trials (360) 360
ipilimumab (357) 357
apoptosis (350) 350
male (328) 328
female (319) 319
pd-1 protein (301) 301
pd-l1 protein (278) 278
antibodies, monoclonal, humanized - therapeutic use (277) 277
middle aged (274) 274
aged (269) 269
care and treatment (266) 266
pd-1 (245) 245
immunology (242) 242
cell death (208) 208
pd-l1 (204) 204
non-small cell lung carcinoma (200) 200
programmed cell death 1 receptor - antagonists & inhibitors (200) 200
antibodies, monoclonal, humanized - adverse effects (196) 196
biomarkers (192) 192
medical prognosis (190) 190
mutation (186) 186
case report (183) 183
atezolizumab (180) 180
lymphocytes (178) 178
adult (169) 169
antineoplastic agents, immunological - therapeutic use (167) 167
drug therapy (165) 165
ligands (161) 161
lung neoplasms - drug therapy (161) 161
treatment outcome (159) 159
cytotoxicity (158) 158
survival (157) 157
immune checkpoint inhibitors (155) 155
lymphocytes t (152) 152
monoclonal antibodies (151) 151
neoplasms. tumors. oncology. including cancer and carcinogens (148) 148
antineoplastic agents - therapeutic use (147) 147
immunotherapy - methods (146) 146
carcinoma, non-small-cell lung - drug therapy (145) 145
review (145) 145
pharmacology & pharmacy (141) 141
toxicity (140) 140
antibodies (138) 138
aged, 80 and over (136) 136
fda approval (136) 136
melanoma - drug therapy (136) 136
antibodies, monoclonal - therapeutic use (133) 133
lung cancer, non-small cell (131) 131
medical research (131) 131
analysis (126) 126
general & internal medicine (126) 126
research (126) 126
immune system (124) 124
medicine, general & internal (124) 124
small cell lung carcinoma (124) 124
antigens (122) 122
response rates (116) 116
non-small cell lung cancer (115) 115
antineoplastic agents, immunological - adverse effects (114) 114
checkpoint inhibitors (114) 114
medicine & public health (113) 113
programmed cell death 1 receptor - immunology (112) 112
antibodies, monoclonal, humanized - administration & dosage (110) 110
health aspects (108) 108
immune checkpoint inhibitor (108) 108
abridged index medicus (103) 103
dermatology (103) 103
lymphoma (102) 102
b7-h1 antigen - antagonists & inhibitors (98) 98
hematology (97) 97
medicine, research & experimental (96) 96
research & experimental medicine (96) 96
inhibitors (95) 95
prognosis (94) 94
radiation therapy (89) 89
antineoplastic combined chemotherapy protocols - therapeutic use (87) 87
immunoglobulins (86) 86
studies (86) 86
development and progression (83) 83
immune response (82) 82
durvalumab (80) 80
platinum (80) 80
antineoplastic agents - adverse effects (78) 78
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2252) 2252
German (17) 17
Russian (16) 16
French (12) 12
Chinese (11) 11
Korean (11) 11
Japanese (7) 7
Spanish (4) 4
Czech (3) 3
Italian (3) 3
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Susac’s syndrome as an immune-related adverse event after pembrolizumab: a case report
by De Groot M and Compter A and De Langen A J and Brandsma D
Journal of neurology, ISSN 0340-5354, 01/2020, Volume 267, Issue 1, pp. 282 - 284
Pembrolizumab
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Anhaltende komplette Remission eines extranodalen NK/T‐Zell‐Lymphoms vom nasalen Typ unter Pembrolizumab und Radiotherapie
by Klee, Gina and Dücker, Laura and Terheyden, Patrick
Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 09/2020, Volume 18, Issue 9, pp. 1019 - 1021
Remission | Pembrolizumab
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
by Brastianos, Priscilla K and Lee, Eudocia Quant and Cohen, Justine V and Tolaney, Sara M and Lin, Nancy U and Wang, Nancy and Chukwueke, Ugonma and White, Michael D and Nayyar, Naema and Kim, Albert and Alvarez-Breckenridge, Christopher and Krop, Ian and Mahar, Maura Keeley and Bertalan, Mia S and Shaw, Brian and Mora, Joana L and Goss, Nathaniel and Subramanian, Megha and Nayak, Lakshmi and Dietrich, Jorg and Forst, Deborah A and Nahed, Brian V and Batchelor, Tracy T and Shih, Helen A and Gerstner, Elizabeth R and Moy, Beverly and Lawrence, Donald and Giobbie-Hurder, Anita and Carter, Scott L and Oh, Kevin and Cahill, Daniel P and Sullivan, Ryan J
Nature medicine, ISSN 1078-8956, 08/2020, Volume 26, Issue 8, pp. 1309 - 1309
Pembrolizumab | Meninges | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Komplette Remission eines Patienten mit metastasierten Uveamelanom nach initialem Progress unter Immuntherapie mit Pembrolizumab
by Camila Toledo Stauner and Konstantin Drexler and Mark Berneburg and Sebastian Haferkamp
Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 11/2018, Volume 16, Issue 11, pp. 1376 - 1378
Pembrolizumab | Remission
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Cochrane Rapid Reviews: Immun-Checkpoint-Inhibitor Pembrolizumab vs. Chemotherapie zur Behandlung von fortgeschrittenen Urothelkarzinomen
by D Wilborn and S Schmidt
Urologe. Ausgabe A, ISSN 0340-2592, 01/2019, Volume 58, Issue 1, pp. 45 - 48
Pembrolizumab
Journal Article
Details down arrow
6. Eine Phase-III-Studie zur pro-aktiven Therapiebegleitung unter Behandlung mit Sunitinib oder Pembrolizumab in Kombination mit Axitinib bzw. Avelumab in Kombination mit Axitinib eines fortgeschrittenen oder metastasierten Nierenzellkarzinoms (PREPARE) – AUO-Nr. AN 49/18
Urologe. Ausgabe A, ISSN 0340-2592, 09/2020, Volume 59, Issue 9, pp. 1157 - 1159
Pembrolizumab
Journal Article
Details down arrow
7. Full Text Complete response to pembrolizumab after initial progress in a patient with metastatic uveal melanoma
by Camila Toledo Stauner and Konstantin Drexler and Mark Berneburg and Sebastian Haferkamp
Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 11/2018, Volume 16, Issue 11, pp. 1376 - 1378
Pembrolizumab | Melanoma | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Current status and perspectives in immunotherapy for metastatic melanoma
by Marconcini, Riccardo and Spagnolo, Francesco and Stucci, Luigia Stefania and Ribero, Simone and Marra, Elena and de Rosa, Francesco and Picasso, Virginia and di Guardo, Lorenza and Cimminiello, Carolina and Cavalieri, Stefano and Orgiano, Laura and Tanda, Enrica and Spano, Laura and Falcone, Alfredo and Queirolo, Paola and Palmieri, Giuseppe and Stanganelli, Ignazio and Mandalà, Mario and Quaglino, Pietro and Botti, Gerardo and Caracò, Corrado and Sileni, Vanna Chiarion and di Giacomo, Anna Maria and Italian Melanoma Intergroup (IMI) and for the Italian Melanoma Intergroup (IMI)
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 15, pp. 12452 - 12470
Pembrolizumab | Immunotherapy | Ipilimumab | Nivolumab | Melanoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text PEMBROLIZUMAB‐RELATED FOATAL MYOCARDITIS ‐ A CASE REPORT
Respirology (Carlton, Vic.), ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 214 - 214
Myocarditis | Heart diseases | Pembrolizumab
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A CASE OF LARGE CELL LUNG CANCER SUCCESSFULLY TREATED WITH PEMBROLIZUMAB, BUT COMPLICATED WITH CHOLANGITIS
Respirology (Carlton, Vic.), ISSN 1323-7799, 11/2019, Volume 24, Issue S2, pp. 179 - 179
Pembrolizumab | Lung cancer | Cholangitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Choosing PD-1 Inhibitors in Oncology Setting, Left or Right?-Lessons From Value Assessment With ASCO-VF and ESMO-MCBS
by Jiang, Qian and Feng, Mei and Li, Youping and Lang, Jinyi and Wei, Hua and Yu, Ting
Frontiers in pharmacology, ISSN 1663-9812, 2020, Volume 11, pp. 574511 - 574511
pembrolizumab | framework | nivolumab | pharmacoecnomics | value
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability
by Munari, Enrico and Zamboni, Giuseppe and Marconi, Marcella and Sommaggio, Marco and Brunelli, Matteo and Martignoni, Guido and Netto, George J and Moretta, Francesca and Mingari, Maria Cristina and Salgarello, Matteo and Terzi, Alberto and Picece, Vincenzo and Pomari, Carlo and Lunardi, Gianluigi and Cavazza, Alberto and Rossi, Giulio and Moretta, Lorenzo and Bogina, Giuseppe
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 52, pp. 90123 - 90131
PD-L1 | Pembrolizumab | SP263 | Immunotherapy | Lung cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text HL-307: A Retrospective Analysis of Brentuximab Vedotin and Pembrolizumab Combination as Salvage Treatment for Patients with Relapsed or Refractory Hodgkin Lymphoma
by Massaro, Fulvio and Maerevoet, Marie and Meuleman, Nathalie
Clinical lymphoma, myeloma and leukemia, ISSN 2152-2650, 09/2020, Volume 20, pp. S250 - S250
pembrolizumab | Hodgkin lymphoma | brentuximab vedotin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text PD-1 inhibitor-related pneumonitis in advanced cancer patients: Radiographic patterns and clinical course
by Nishino, Mizuki and Ramaiya, Nikhil H and Awad, Mark M and Sholl, Lynette M and Maattala, Jennifer A and Taibi, Myriam and Hatabu, Hiroto and Ott, Patrick A and Armand, Philippe F and Hodi, F. Stephen
Clinical cancer research, ISSN 1078-0432, 12/2016, Volume 22, Issue 24, pp. 6051 - 6060
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus | pembrolizumab | PD-1 inhibitor | nivolumab | pneumonitis | immune-related adverse event
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
by Oishi, Hideo and Morimoto, Ryota and Shimoyama, Yoshie and Kuroda, Kei and Urata, Toru and Kondo, Toru and Okumura, Takahiro and Bando, Yasuko K and Akiyama, Masashi and Murohara, Toyoaki
JACC: Case Reports, ISSN 2666-0849, 10/2020, Volume 2, Issue 12, pp. 1937 - 1941
pembrolizumab | myocardial injury | vasculitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Boosting immune responses against early breast cancer
by Ileana-Dumbrava, Ecaterina
Science translational medicine, ISSN 1946-6234, 03/2020, Volume 12, Issue 535, p. eabb2773
Chemotherapy | Pembrolizumab | Breast cancer | Immune response
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: An open-label, phase 2 trial
by Planchard, David and Smit, Egbert F and Groen, Harry J. M and Mazieres, Julien and Besse, Benjamin and Helland, Aslaug and Giannone, Vanessa and D'Amelio, Anthony M and Zhang, Pingkuan and Mookerjee, Bijoyesh and Johnson, Bruce E
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1307 - 1316
SURVIVAL | HARBORING BRAF MUTATIONS | 1ST-LINE TREATMENT | MULTICENTER | MELANOMA | PEMBROLIZUMAB | CRIZOTINIB | MULTICOHORT | CHEMOTHERAPY | EGFR | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text A Fatal Case of Pembrolizumab-Induced Myocarditis in Non–Small Cell Lung Cancer
by Cohen, Max and Mustafa, Saim and Elkherpitawy, Islam and Meleka, Matthew
JACC: Case Reports, ISSN 2666-0849, 03/2020, Volume 2, Issue 3, pp. 426 - 430
pembrolizumab | myocarditis | fatal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
by Matulonis, U.A and Shapira-Frommer, R and Santin, A.D and Lisyanskaya, A.S and Pignata, S and Vergote, I and Ottevanger, P.B and Ruman, J and Ledermann, J.A
Annals of oncology, ISSN 0923-7534, 2019, Volume 30, Issue 7, pp. 1080 - 1087
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
by Cantini, Luca and Pecci, Federica and Hurkmans, Daan P and Belderbos, Robert A and Lanese, Andrea and Copparoni, Cecilia and Aerts, Sophie and Cornelissen, Robin and Dumoulin, Daphne W and Fiordoliva, Ilaria and Rinaldi, Silvia and Aerts, Joachim G.J.V and Berardi, Rossana
European journal of cancer (1990), ISSN 0959-8049, 02/2021, Volume 144, pp. 41 - 48
Mesothelioma | Pembrolizumab | Statin | Lung cancer | Immunotherapy | Nivolumab | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.